Insights - AcelRx Pharmaceuticals (ACRX) announced on Monday a partnership with Grunenthal GmbH for the commercialization of Zalviso, the company’s patient-controlled analgesia product, in Europe and Australia. AcelRx will receive $30 … Continue Reading
Read nowInsights - Coronado Biosciences (CNDO) on Thursday after the bell announced that an early and small study of its lead candidate, TSO (Trichuris suis ova, CNDO-201, or … Continue Reading
PremiumInsights - Sarepta Therapeutics (SRPT) traded as high as $20.79 on Thursday morning following comments from the director of the FDA’s Center for Drug Evaluation and Research (CDER), Janet Woodcock, … Continue Reading
Read nowInsights - -Buy near recent financing price. Stock is attractive into year-end, but more importantly, could be a top biotech play in 2014. Note that stock is relatively … Continue Reading
PremiumInsights - In two press releases on Monday morning, Hologic (HOLX) announced the hiring of a new CEO and the addition of two new independent members to … Continue Reading
PremiumInsights - In the Tuesday trading session, shares of Sunshine Heart (SSH) briefly touched and bounced from their 200-day moving average at $7.72. SSH, on which PropThink … Continue Reading
PremiumInsights - Orexigen Therapeutics’ (OREX) obesity drug Contrave did not increase the risk of cardiovascular events (heart attack, etc.) past a specified threshold in an interim look … Continue Reading
Premium
